Lewis C. Perrin

Herston, QLD, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Small Extracellular Vesicle and Total Lipid Profiles Provide a Diagnostic Advantage Over CA-125 Across Ovarian Cancer Subtypes.

Small Extracellular Vesicle and Total Lipid Profiles Provide a Diagnostic Advantage Over CA-125 Across Ovarian Cancer Subtypes.

Journal: Journal of extracellular vesicles

Published: August 23, 2025

Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer.

Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer.

Journal: British journal of cancer

Published: July 24, 2025

Enhancing treatment outcomes after gynaecological cancer (ACUMEN): a randomised controlled exercise trial protocol.

Enhancing treatment outcomes after gynaecological cancer (ACUMEN): a randomised controlled exercise trial protocol.

Journal: BMC cancer

Published: April 27, 2025

Antigen presentation potential is variable among human ovarian tumour and syngeneic murine models and dictates pre-clinical outcomes of immunotherapy.

Antigen presentation potential is variable among human ovarian tumour and syngeneic murine models and dictates pre-clinical outcomes of immunotherapy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 27, 2024

Extracellular vesicle miRNAs from three-dimensional ovarian cancer in vitro models and their implication in overall cancer survival.

Extracellular vesicle miRNAs from three-dimensional ovarian cancer in vitro models and their implication in overall cancer survival.

Journal: Heliyon

Published: June 25, 2024

High-throughput surface epitope immunoaffinity isolation of extracellular vesicles and downstream analysis.

High-throughput surface epitope immunoaffinity isolation of extracellular vesicles and downstream analysis.

Journal: Biology methods & protocols

Published: April 03, 2024

Establishing the sensitivity and specificity of the gynaecological cancer distress screen.

Establishing the sensitivity and specificity of the gynaecological cancer distress screen.

Journal: Psycho-oncology

Published: August 09, 2023

Safety and feasibility of hyperthermic intraperitoneal chemotherapy during interval cytoreductive surgery in patients with advanced high-grade serous ovarian, fallopian tube, peritoneal cancer in an Australian context.

Safety and feasibility of hyperthermic intraperitoneal chemotherapy during interval cytoreductive surgery in patients with advanced high-grade serous ovarian, fallopian tube, peritoneal cancer in an Australian context.

Journal: The Australian & New Zealand journal of obstetrics & gynaecology

Published: February 20, 2023

Endometrial cancer PDX-derived organoids (PDXOs) and PDXs with FGFR2c isoform expression are sensitive to FGFR inhibition.

Endometrial cancer PDX-derived organoids (PDXOs) and PDXs with FGFR2c isoform expression are sensitive to FGFR inhibition.

Journal: NPJ precision oncology

Published: January 25, 2023

Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer.

Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer.

Journal: Proteomics. Clinical applications

Published: December 16, 2022

Proteolytic and mechanical remodeling of the extracellular matrix by invadopodia in cancer.

Proteolytic and mechanical remodeling of the extracellular matrix by invadopodia in cancer.

Journal: Physical biology

Published: March 31, 2022

Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian Cancer.

Preclinical Evaluation of a Fluorescent Probe Targeting Receptor CDCP1 for Identification of Ovarian Cancer.

Journal: Molecular pharmaceutics

Published: August 27, 2021

Showing 1-12 of 45

Last Updated: 09/26/2026